Axogen, Inc. Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
Axogen, Inc. (AXGN) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of $1.61 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Debt
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2026-02-24
- 2025-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $1.61M.
- 2025-09-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $1.84M.
- 2025-06-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $2.06M.
- 2025-03-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $2.28M.
| Period end | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net |
|---|---|
| 2025-12-31 | $1.61M 10-K · filed 2026-02-24 |
| 2025-09-30 | $1.84M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $2.06M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $2.28M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $2.50M 10-K · filed 2026-02-24 |
| 2024-09-30 | $2.73M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.95M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $3.17M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $3.40M 10-K · filed 2025-02-26 |
| 2023-09-30 | $3.62M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $3.85M 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$4.07M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $4.29M 10-K · filed 2024-03-05 |
| 2022-09-30 | $4.51M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $4.74M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $4.96M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $5.18M 10-K · filed 2023-03-14 |
| 2021-09-30 | $3.76M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $3.92M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $2.86M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $2.97M 10-K · filed 2022-02-25 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-01 |
| 2018-05-22 | $473.00K 10-K · filed 2020-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |